Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: Treatment of Diabetic Foot Ulcers With AUP1602-C [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for AUP1602-C in treating diabetic foot ulcers completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AUP1602-C

Snippet

Sponsor: Aurealis Oy | Conditions: Diabetic Foot Ulcer | Phase 1, Phase 2 | Status: COMPLETED